Presentation is loading. Please wait.

Presentation is loading. Please wait.

A Comprehensive Approach to Kidney Disease and Hypertension

Similar presentations


Presentation on theme: "A Comprehensive Approach to Kidney Disease and Hypertension"— Presentation transcript:

1 A Comprehensive Approach to Kidney Disease and Hypertension
Dr. Eddy Susatyo, SpPD SubBag Ginjal dan Hipertensi Ilmu Penyakit Dalam RSI ARAFAH/ RSUD Rembang

2 Ginjal Fungsi Ginjal Regulasi volume cairan
Regulasi keseimbangan elektrolit Regulasi keseimbangan asam dan basa Regulasi tekanan darah (RAAS) Regulasi eritropoesis Ekskresi sampah metabolik Metabolisme vitamin D Sintesis prostaglandin

3

4

5 Apa penyebab Gagal Ginjal ?

6 Akut Gagal Ginjal Kronik

7 Chronic CKD: Chronic Kidney Disease Acute ARF: Acute Renal Failure AKI: Acute Kidney Injury Acute Classification Pre-renal Renal Post-renal

8

9 The CKD problem Clinically silent in the early stages
Cost of renal disease can be extreme to health care service Effects of renal disease can be extreme on patient Treatments now available to slow progression Need an “early warning” system for CKD

10 All global renal diseases affect glomerular filtration rate (GFR)‏
Diseases of the Kidney Diabetes Hypertension Atherosclerosis Glomerular diseases Toxins Gentamicin NSAIDS Compound analgesics Inherited diseases Tubular disorders All global renal diseases affect glomerular filtration rate (GFR)‏

11

12 Glomerular Filtration Rate is the volume of fluid passing through the glomerulus in a given period of time. Influenced by renal perfusion pressure, renal vascular resistance, glomerular damage, post-glomerular resistance. “Normal Range” approx mL/min Approx 170 L per day A larger healthy person has a higher GFR Can be reported as mL/min/1.73m2 Values fall with increasing age

13 Other reasons for estimating the GFR
Monitoring progression of CKD GFR estimates are used for drug dosing decisions Dosing of renally excreted drugs Avoiding nephrotoxic drugs Risk factor for cardiovascular disease mortality Renal involvement in systemic diseases, such as diabetes mellitus or SLE

14 Estimate of GFR Measured GFR Serum creatinine Creatinine clearance
Formulae based on serum creatinine Cockcroft and Gault MDRD Other Eg Cystatin C All based on measurements of serum creatinine

15 Equations for Estimating GFR
Abbreviated MDRD Study Equation GFR (mL/min/1.73 m2) =  SCr  Age  (if female)  (if African American) Cockcroft-Gault Equation (140 – Age)  Weight in kg Ccr = (mL/min)‏  0.85 if female 72  SCr MDRD = Modification of Diet in Renal Disease; Ccr = creatinine clearance. Levey et al. Ann Intern Med. 2003;139:

16

17 Definition of CKD Kidney damage for 3 months
Defined by structural or functional abnormalities of the kidney, with or without decreased glomerular filtration rate (GFR)‏ Reduced GFR for 3 months New staging for chronic kidney disease (CKD) is primarily based on kidney function. National Kidney Foundation (NKF). Am J Kidney Dis. 2002;39(2 suppl 1):S1-S266.

18 Prevalence of CKD

19 The Most Common Causes of CKD
Diabetes 50.1% Hypertension 27% Glomerulonephritis 13% Other 10% Primary Diagnosis for Patients Who Start on Dialysis

20 STAGES OF CKD COMPLICATIONS CKD DEATH INCREASED RISK NORMAL DAMAGE
LOW GFR RENAL FAILURE CKD DEATH COMPLICATIONS

21 Bagaimana dengan Anemia Renal ?

22 Anemia Rates Increase as Levels of CKD Severity Progress
100 Anemia Prevalence (%)‏ 62 15 10 Hgb Values 80 11-12 g/dL 43 8 15 10-11 g/dL 60 <10 g/dL 40 20 8 17 14 9 5 20 <2 2-2.9 3-3.9 ≥4 Creatinine (mg/dL)‏ Chronic Kidney Disease (CKD) Progression Hgb = hemoglobin. Kausz et al. Dis Manage Health Outcomes. 2002;10:

23 Normal Gagal Ginjal

24

25

26

27

28 Chronic kidney disease (CKD)
Anemia is an expected complication of CKD Treatment Increased cardiovascular morbidity recombinant human erythropoietin (r-HuEPO) Left Ventricular Hypertrophy (LVH) Congestive Heart Failure (CHF)

29 Diambil : Jerome Rossert dkk, Nephrol Dial Transplant (2002) 17: 359–362

30

31 INFLAMMATION plus CaP deposition
Why are CKD/ESRD Patients Predisposed to CV Disease? CKD/ESRD ANEMIA LVH/CHF LIPIDS HTN INFLAMMATION plus CaP deposition CV DISEASE AND DEATH CAD and PVD

32 Why are CKD/ESRD Patients Predisposed to CV Disease?
30-50% of ESRD patients have INFLAMMATION (increased CRP, increased IL-6, decreased albumin)‏ Increased CRP is a primary marker for inflammation predicting cardiovascular disease in normal adults Increased CRP is the primary marker for increased cardiovascular mortality on dialysis CKD/ESRD patients have metastatic calcification (coronary arteries) because of secondary hyperparathyroidism and elevated PO4 levels.

33 Bagaimana hubungan antara hipertensi dengan CKD ?

34 Distribution of hypertensives (65-89 years)
ISOLATED SYSTOLIC ISOLATED SYSTOLIC COMBINED COMBINED ISOLATED DIASTOLIC ISOLATED DIASTOLIC Framingham study

35 Factors Affecting Blood Pressure Total Peripheral Resistance
= Cardiac Output X Amount of blood ejected per minute Blood flow through blood vessels

36

37

38 Prevalence of HTN in CKD
80% of patients with glomerulonephritis and 30% of patients with chronic interstitial disease are hypertensive.

39

40

41 Klahr S et al, N Engl J Med 330:877, 1994
Aggressive BP Control, Proteinuria and CKD Progression – what is the optimal BP for CKD? * * Klahr S et al, N Engl J Med 330:877, 1994 GOAL BP<125/75 if >1 gm proteinuria

42 A II Angiotensin II plays a central role in organ damage
Atherosclerosis* Vasoconstriction Vascular hypertrophy Endothelial dysfunction Stroke Hypertension A II LV hypertrophy Fibrosis Remodeling Apoptosis Heart Failure MI Death GFR Proteinuria Aldosterone release Glomerular sclerosis Renal Failure *Preclinical data. LV = left ventricular; MI = myocardial infarction; GFR = glomerular filtration rate.

43 Non-ACE pathways (eg, chymase)‏
Renin Angiotensin Aldosterone System Non-ACE pathways (eg, chymase)‏ Vasoconstriction Cell growth Na/H2O retention Sympathetic activation Angiotensinogen AT1 Renin Angiotensin I Angiotensin II ACE Aldosterone AT2 Cough, angioedema Benefits? Vasodilation Antiproliferation (kinins)‏ Inactive fragments  Bradykinin

44 Decreased vasodilatory prostaglandins Increased angiotensin II Low GFR

45 How About Renal Osteodystrophy

46 Bone Disease in CKD Metabolic abnormalities Hyperphosphatemia
Hypocalcemia PTH elevation

47 Bone Disease in CKD Renal Osteodystrophy
Osteomalacia / osteitis fibrosis cystica / osteosclerosis Metastatic calcification Vascular!

48 Bone Disease in CKD Renal Osteodystrophy

49

50 Matur nuwun


Download ppt "A Comprehensive Approach to Kidney Disease and Hypertension"

Similar presentations


Ads by Google